- Home
- EVTL vs ITOS Comparison
EVTL vs ITOS Comparison
Compare EVTL & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- ITOS
- Stock Information
- Founded
- EVTL 2016
- ITOS 2011
- Country
- EVTL United Kingdom
- ITOS United States
- Employees
- EVTL N/A
- ITOS N/A
- Industry
- EVTL Aerospace
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVTL Industrials
- ITOS Health Care
- Exchange
- EVTL Nasdaq
- ITOS Nasdaq
- Market Cap
- EVTL 467.9M
- ITOS 381.2M
- IPO Year
- EVTL N/A
- ITOS 2020
- Fundamental
- Price
- EVTL $7.08
- ITOS $10.18
- Analyst Decision
- EVTL Buy
- ITOS Hold
- Analyst Count
- EVTL 6
- ITOS 6
- Target Price
- EVTL $11.70
- ITOS $10.60
- AVG Volume (30 Days)
- EVTL 966.4K
- ITOS 911.5K
- Earning Date
- EVTL 03-11-2025
- ITOS 08-07-2025
- Dividend Yield
- EVTL N/A
- ITOS N/A
- EPS Growth
- EVTL N/A
- ITOS N/A
- EPS
- EVTL N/A
- ITOS N/A
- Revenue
- EVTL N/A
- ITOS $35,000,000.00
- Revenue This Year
- EVTL N/A
- ITOS N/A
- Revenue Next Year
- EVTL N/A
- ITOS N/A
- P/E Ratio
- EVTL N/A
- ITOS N/A
- Revenue Growth
- EVTL N/A
- ITOS 177.89
- 52 Week Low
- EVTL $2.76
- ITOS $4.80
- 52 Week High
- EVTL $15.99
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- EVTL 61.09
- ITOS 67.13
- Support Level
- EVTL $6.22
- ITOS $9.95
- Resistance Level
- EVTL $6.94
- ITOS $10.19
- Average True Range (ATR)
- EVTL 0.54
- ITOS 0.15
- MACD
- EVTL 0.08
- ITOS -0.09
- Stochastic Oscillator
- EVTL 86.13
- ITOS 84.75
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.